ArticleMolecular and clinical oncology2018

Survival-associated factors of first-line EGFR-tyrosine kinase inhibitor responders and non-responders in lung adenocarcinoma patients with common

Ming-Szu Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.